https://www.roche.com/investors/updates/inv-update-2021-08-02
FDA expands authorized use of REGEN-COV (casirivimab and imdevimab)
Dear Investor, Please find attached a press release from our partner Regeneron: ...
casirivimab and imdevimabauthorized usefdaexpandsregen
https://medicalchannelasia.com/infectious-disease/casirivimab-and-imdevimab-an-overview-of-its-use-in-covid-19-treatment/
Casirivimab and Imdevimab: An Overview of its use in COVID-19 treatment - Medical Channel Asia
Mar 15, 2026 - Casirivimab and Imdevimab are the active ingredients in Regen-COV, a new medication for COVID-19 treatment. How does it work?
casirivimab and imdevimabmedical channel asiaoverviewusecovid
https://scholars.houstonmethodist.org/en/publications/effectiveness-of-casirivimab-and-imdevimab-antibody-combination-i/fingerprints/
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized...
casirivimab and imdevimabeffectivenessantibodycombinationhospitalized
https://elmi.hbku.edu.qa/en/publications/casirivimab-and-imdevimab-in-patients-admitted-to-hospital-with-c/
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised,...
casirivimab and imdevimabin patientsadmittedhospitalcovid